Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant GAD antibody

The Rabbit Monoclonal anti-GAD antibody (Clone AAGO-7) (ABIN8093205) specifically detects GAD in WB and IHC. The antibody is reactive with Human, Mouse, Rat and Pig samples.
Catalog No. ABIN8093205
$625.62
Plus shipping costs $50.00
100 μL
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for Recombinant GAD antibody (ABIN8093205)

Target

See all GAD (GAD1) Antibodies
GAD (GAD1) (Glutamate Decarboxylase 1 (Brain, 67kDa) (GAD1))

Antibody Type

Recombinant Antibody

Reactivity

  • 167
  • 81
  • 76
  • 6
  • 6
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Human, Mouse, Rat, Pig

Host

  • 124
  • 49
  • 3
  • 2
Rabbit

Clonality

  • 111
  • 67
Monoclonal

Conjugate

  • 76
  • 15
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This GAD antibody is un-conjugated

Application

  • 112
  • 57
  • 36
  • 29
  • 17
  • 17
  • 14
  • 13
  • 13
  • 13
  • 11
  • 5
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)

Clone

AAGO-7
  • Purpose

    GAD67 Antibody / GAD1 / Glutamate decarboxylase 1

    Purification

    Affinity chromatography

    Immunogen

    A synthesized peptide derived from human Glutamate decarboxylase 1 protein was used as the immunogen for the Glutamate decarboxylase 1 antibody.

    Isotype

    IgG
  • Application Notes

    Optimal dilution of the Glutamate decarboxylase 1 antibody should be determined by the researcher.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    Store the Glutamate decarboxylase 1 antibody at -20oC.
  • Target

    GAD (GAD1) (Glutamate Decarboxylase 1 (Brain, 67kDa) (GAD1))

    Alternative Name

    GAD67

    Background

    Glutamate decarboxylase 1 antibody targets Glutamate decarboxylase 1 (GAD1), also commonly referred to as GAD67, a pyridoxal phosphate-dependent enzyme responsible for catalyzing the conversion of glutamate to gamma-aminobutyric acid (GABA). GAD1 is predominantly localized in the cytoplasm of inhibitory neurons, where it plays a central role in neurotransmitter biosynthesis. As one of the two major glutamate decarboxylase isoforms, GAD67 contributes to the basal production of GABA required for maintaining inhibitory tone within the central nervous system.

    Functionally, GAD1 is essential for regulating excitatory-inhibitory balance in neuronal circuits. By producing GABA, GAD1 supports synaptic inhibition, neuronal firing control, and network stability. Unlike the closely related GAD2 (GAD65), which is more tightly associated with synaptic vesicles and activity-dependent GABA synthesis, GAD1 is distributed more broadly within neurons and is thought to supply GABA for both synaptic and non-synaptic functions. A Glutamate decarboxylase 1 antibody supports studies focused on inhibitory neurotransmission and neuronal metabolism.

    GAD1 expression is highly enriched in GABAergic neurons throughout the brain and spinal cord, including regions such as the cortex, hippocampus, cerebellum, and basal ganglia. Its expression pattern is often used as a marker to identify inhibitory neuronal populations in both developmental and adult nervous systems. Analysis of GAD1 localization and abundance provides valuable insight into the organization of inhibitory circuits and changes in neuronal phenotype under different physiological or experimental conditions.

    From a biological and disease-relevance perspective, altered GAD1 expression or activity has been associated with a range of neurological and psychiatric conditions. Dysregulation of GABA synthesis can disrupt neural circuit balance and has been implicated in epilepsy, schizophrenia, anxiety disorders, and neurodevelopmental abnormalities. GAD1 is also of interest in studies of synaptic plasticity, neuronal differentiation, and brain development. Monitoring GAD1 expression helps clarify how inhibitory signaling contributes to both normal brain function and disease-associated phenotypes.

    At the molecular level, GAD1 is encoded by the GAD1 gene and produces a protein of approximately 67 kDa, giving rise to the commonly used name GAD67. The enzyme requires pyridoxal phosphate as a cofactor for catalytic activity and forms functional homodimers in cells. Regulation of GAD1 occurs at transcriptional, post-transcriptional, and protein stability levels, allowing precise control of GABA production. A Glutamate decarboxylase 1 antibody supports research applications focused on neurotransmitter biosynthesis, inhibitory neuron identification, and neural circuit analysis, with NSJ Bioreagents providing reagents intended for research use.

    For highly specific detection of GAD67 in inhibitory neurotransmitter pathway studies, see our < a href=../tds/gad67-antibody-gad1-gad12391-v3854>GAD67 Antibody / GABA Synthesis Enzyme Antibody page featuring strong HuProt(TM) microarray specificity validation data.

    UniProt

    Q99259
You are here:
Chat with us!